A Rapid Method for Multispectral Fluorescence Imaging of Frozen Tissue Sections
March 30th, 2020
9.7K views
We describe a rapid staining method to perform multispectral imaging on frozen tissues.
Overview
This article describes a rapid staining method for multispectral imaging on frozen tissues, allowing for the detection and co-localization of multiple biomarkers in a single cryosection. The method significantly reduces staining time and can be performed in any laboratory.
Key Study Components
Area of Science
- Neuroscience
- Biotechnology
- Immunology
Background
- Traditional paraffin sections limit the detection of certain biomarkers.
- Frozen tissue sections provide better preservation of biomarker integrity.
- Multispectral imaging allows for simultaneous analysis of multiple markers.
- Rapid staining methods enhance laboratory efficiency.
Purpose of Study
- To develop a staining method that is quick and effective for frozen tissues.
- To enable the detection of biomarkers that are typically undetectable in paraffin sections.
- To facilitate the use of this method in various laboratory settings.
Methods Used
- Selection of appropriate antibodies based on excitation and emission filter sets.
- Testing various combinations of fluorophore conjugated primary antibodies.
- Preparation of fluorophores to minimize spectral overlap.
- Demonstration of the method by a skilled postdoc.
Main Results
- The method allows for the co-localization of multiple biomarkers.
- Staining time is significantly reduced compared to traditional methods.
- Can be performed in any laboratory setting, enhancing accessibility.
- Demonstrated effectiveness in detecting normally undetectable markers.
Conclusions
- The rapid staining method is a valuable tool for researchers.
- It expands the capabilities of multispectral imaging in frozen tissues.
- This approach can lead to more comprehensive biomarker analysis.
Frequently Asked Questions
What are the advantages of using frozen tissues?
Frozen tissues preserve biomarker integrity better than paraffin sections, allowing for more accurate detection.
How does this method reduce staining time?
The rapid staining method streamlines the process, allowing for quicker preparation and analysis.
Can this method be used in any laboratory?
Yes, the method is designed to be simple enough for use in various laboratory settings.
What should be considered when selecting antibodies?
Consider the excitation and emission filter sets available on the imaging system to ensure compatibility.
Who demonstrated this staining method?
Dinesh Jaishankar, a skilled postdoc, demonstrated the method.
What is the significance of minimizing spectral overlap?
Minimizing spectral overlap ensures clearer imaging results and more accurate biomarker detection.
Executive Industry Relevance
This method enables rapid multiplex biomarker detection in frozen tissue sections, addressing a key limitation of FFPE-based assays where certain biomarkers are undetectable due to fixation artifacts or antibody incompatibility. By reducing staining time and leveraging commercially available multispectral imaging systems, it supports faster hypothesis testing in discovery immunology and oncology programs. The approach enhances predictive confidence in target validation by enabling spatial co-localization analysis of immune and tumor markers in clinically relevant tissue models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through simultaneous detection of up to six markers in a single cryosection, clarifying antigen co-expression patterns.
- Operational Value: Reduces staining time significantly compared to traditional methods, accelerating early-stage biomarker screening workflows.
- Predictive Value: Supports phenotypic characterization of immune infiltrates (e.g., B-cells, T-cells, macrophages) in frozen human and mouse tissues, aiding functional target de-risking.
Screening & Assay Development
- Scientific Value: Facilitates preparation of validated biological systems for downstream workflows by generating spectral libraries from single-stained controls, ensuring minimal spectral overlap.
- Operational Value: Uses a semi-automated multispectral imaging system to standardize acquisition and analysis, improving reproducibility across users and laboratories.
- Scalability: Enables reliable compound evaluation by generating quantitative phenotype maps through machine learning-based cell segmentation and marker detection.
Translational & Preclinical Research
- Translational Continuity: Preserves biomarker integrity in frozen tissues, offering a disease-relevant system for detecting markers not accessible in FFPE sections.
- Preclinical Model Alignment: Demonstrated utility in frozen mouse tumor sections to visualize tumor-infiltrating T-cells and myeloid lineages, supporting mechanistic de-risking in immunotherapy studies.
- Risk-Adjusted Advancement: Enables quantification of stained cells per marker, providing data for go/no-go decisions in target prioritization and portfolio triage.
Pipeline & Workflow Integration
The method fits within the discovery continuum from early target validation through preclinical validation, particularly for immunotherapies where spatial context of biomarker expression is critical for mechanism of action.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling co-localization analysis of multiple biomarkers in intact tissue architecture.
- Screening: Delivers assay readiness through standardized spectral library creation and whole-slide scanning at 20x magnification, ensuring reproducible quantitative outputs.
- Analytics: Generates segmentation maps and phenotype maps via machine learning software, enabling objective comparison of staining conditions and cell populations.
- Translational Research: Connects discovery to preclinical continuity by preserving antigenicity in frozen tissues, allowing detection of markers lost in paraffin processing.
- Enterprise Reuse: Establishes a reusable capability for multiplexed biomarker analysis across projects, reducing dependency on single-use staining protocols.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity through spatial multiplexing.
- Operational Value: Enhances standardization and reproducibility via semi-automated imaging and software-driven spectral unmixing.
- Strategic Value: Improves capital efficiency by enabling rapid go/no-go decisions and reducing late-stage biological risk through early de-risking.
- Portfolio Impact: Supports risk-adjusted prioritization by providing quantitative, spatially resolved biomarker data from clinically relevant tissue models.
Implementation Considerations
- Requires expertise in fluorescence microscopy, antibody selection based on excitation/emission compatibility, and spectral library generation.
- Dependent on access to a semi-automated multispectral imaging system with liquid crystal tunable filter and compatible machine learning analysis software.
- Necessitates cross-team standardization of antibody cocktails, dilution protocols, and staining controls to ensure consistent results across laboratories.
- Requires adaptation of fluorophore panels to minimize spectral overlap, particularly when extending beyond six markers or switching tissue types.
- Practical limitation: Method is optimized for frozen tissues; performance in FFPE sections is not supported and may require re-validation due to antigen accessibility differences.
Biopharma FAQs
Why does spectral unmixing matter for target validation in frozen tissue imaging?
Spectral unmixing enables precise separation of overlapping fluorophore signals, which is critical for accurate co-localization analysis of multiple biomarkers in a single tissue section. This capability supports confident interpretation of antigen expression patterns and reduces false-positive signals in multiplexed assays.
How does isolating primary antibody staining contribute to discovery pipeline efficiency?
Staining single markers first allows creation of a spectral library that serves as a reference for multiplexed imaging, minimizing the need for repeated optimization. This approach reduces reagent waste and accelerates assay development by ensuring compatibility before combining antibodies in a cocktail.
What quantitative outputs enable predictive confidence in biomarker co-expression analysis?
The method generates cell segmentation maps and phenotype maps that quantify the number of stained cells per marker, enabling objective measurement of co-expression frequencies. These outputs support statistical comparison between conditions and help de-risk target hypotheses with reproducible data.
Why are replication requirements important for cross-functional collaboration in multispectral imaging?
Including control unstained slides and replicating staining procedures ensures that observed signals are specific to antibody binding and not due to autofluorescence or non-specific binding. This rigor supports data sharing across teams by establishing assay reliability and reducing variability in interpretation.
What statistical analysis capabilities are required before implementing this method in discovery workflows?
The machine learning software must be trained using classifier models built from phenotyped positive and negative cells to enable automated detection of marker expression. This training step is essential for generating unbiased, quantitative phenotype maps that support downstream statistical analysis and comparison across experimental groups.
Chapters in this video
0:05
Introduction
0:39
Antibody and Fluorophore Selecting and Staining
1:52
Spectral Library Preparation
2:59
Multispectral Imaging
3:54
Spectral Unmixing
4:37
Analyzing Multispectral Images via Cell Segmentation and Phenotyping
5:52
Results: Representative Multispectral Imaging and Cell Quantification
7:07
Conclusion
